News Archive
First test of anti-cancer agent PAC-1 in human clinical trials shows promise
Diana Yates
A phase I clinical trial of PAC-1, a drug that spurs programmed cell death in cancer cells, found only minor side effects in patients with end-stage cancers.
Bill & Melinda Gates Agricultural Innovations extends RIPE funding with $34M grant
Diana Yates
Bill & Melinda Gates Agricultural Innovations has awarded a grant of $34 million to the Realizing Increased Photosynthetic Efficiency project, an international research effo
New journalism master’s degree track focusing on science and technology receives campus funding
Holly Rushakoff
With a significant need for professionals to communicate science, discoveries, and innovations to the general public, a flexible hybrid/online program—with a focus on science an
15 Years of IGB: Integrating Science and Society through Outreach
Shelby Lawson
Since the inception of the Carl R.
Network neuroscience theory best predictor of intelligence
Diana Yates
Scientists have labored for decades to understand how brain structure and functional connectivity drive intelligence.
Research to boost astronaut fitness on NASA’s mission to Mars
Jenna Kurtzweil
Exercise looks a little different en route to the Red Planet, so Professor Marni Boppart (RBTE) got creative.
Biomarker 2022 now available
Ananya Sen
The 16th volume of the Biomarker is now available online at (https://www.igb.illinois.edu/si
CAIM working group
The IGB Center for Artificial Intelligence and Modeling (CAIM) is organizing a monthly working group to facilitate the matching of biological problems to quantitative methods.
Spatial Omics Initiative working group
The IGB Computational Genomics would like to announce the Spatial Omics Initiative, to bring together researchers from different disciplines across the University of Illinois to
Anthony Digrado and Jessica Brinkworth to feature on Story Collider Podcast “Flora”
IGB Comms
Science storytelling organization The Story Collider develops “true, personal stories about science” as part of their mission to reveal the vibrant role that science plays in al
Experts boost activity of potential therapeutic target in triple-negative breast cancer
Diana Yates
Less than 20% of diagnosed breast cancers are designated “triple-negative,” meaning that the affected tissues lack three types of receptors often found in other breast cancer ty
